Accession Number: | 0001179110-20-006837 |
Date: | 2020-05-29 |
Issuer: | ABIOMED INC (ABMD) |
Original Submission Date: |
WEBER DAVID M
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS, MA 01923
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $.01 PAR VALUE | 2020-05-29 | A | 3,033 | a | $0.00 | 124,932 | direct | ||
COMMON STOCK, $.01 PAR VALUE | 2020-05-29 | 0 | $0.00 | 15,497 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 223.9 | 2020-05-29 | deemed execution date | A | 5,000 (a) | 2021-05-29 | 2030-05-29 | common stock 5,000 | $223.90 | 5,000 | direct | |
STOCK OPTION (RIGHT TO BUY) | 23.15 | 2020-05-29 | deemed execution date | 0 ( ) | 2014-05-14 | 2023-05-14 | common stock 0 | $23.15 | 13,000 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 21.55 | 2020-05-29 | deemed execution date | 0 ( ) | 2015-05-14 | 2024-05-14 | common stock 0 | $21.55 | 10,825 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 66.25 | 2020-05-29 | deemed execution date | 0 ( ) | 2016-05-13 | 2025-05-13 | common stock 0 | $66.25 | 10,000 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 99.62 | 2020-05-29 | deemed execution date | 0 ( ) | 2017-05-24 | 2026-05-24 | common stock 0 | $99.62 | 7,000 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 134.51 | 2020-05-29 | deemed execution date | 0 ( ) | 2018-05-15 | 2027-05-15 | common stock 0 | $134.51 | 8,000 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 381.97 | 2020-05-29 | deemed execution date | 0 ( ) | 2019-05-16 | 2028-05-16 | common stock 0 | $381.97 | 6,500 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 266.39 | 2020-05-29 | deemed execution date | 0 ( ) | 2020-05-30 | 2029-05-30 | common stock 0 | $266.39 | 6,000 | direct |
ID | footnote |
---|---|
f1 | this option becomes exercisable in annual 25% increments, commencing on the date shown in table ii, column 6. |
f2 | grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2008 stock incentive plan. |
f3 | these options become exercisable in annual 33-1/3% increments, commencing on the date shown in table ii, column 6. |
f4 | grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2015 omnibus incentive plan. |
f5 | consists of restricted stock units granted to the reporting person. one third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of may 29, 2021, may 29, 2022 and may 29, 2023, so long as the reporting person continues to be employed by the issuer on the vesting dates. |